dc.contributor.author | Sestak, I | en_US |
dc.contributor.author | Smith, SG | en_US |
dc.contributor.author | Howell, A | en_US |
dc.contributor.author | Forbes, JF | en_US |
dc.contributor.author | Cuzick, J | en_US |
dc.date.accessioned | 2018-02-06T15:23:49Z | |
dc.date.available | 2017-10-23 | en_US |
dc.date.issued | 2018-02 | en_US |
dc.date.submitted | 2017-12-20T11:00:18.255Z | |
dc.identifier.issn | 0923-7534 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/32064 | |
dc.description.sponsorship | Cancer Research UK (C569/A5032 to JC, C42785/A17965 to SGS); and AstraZeneca (no grant number applies). | en_US |
dc.format.extent | 504 - 509 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | ANNALS OF ONCOLOGY | en_US |
dc.rights | This is a pre-copyedited, author-produced version of an article accepted for publication in journal of Annals of Oncology, following peer review. The version of record I Sestak, S G Smith, A Howell, J F Forbes, J Cuzick; Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II, Annals of Oncology is available online at https://doi.org/10.1093/annonc/mdx713 | |
dc.subject | breast cancer | en_US |
dc.subject | prevention | en_US |
dc.subject | adherence | en_US |
dc.subject | endocrine therapy | en_US |
dc.title | Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II | en_US |
dc.type | Article | |
dc.rights.holder | (c) The Author(s) 2017. | |
dc.identifier.doi | 10.1093/annonc/mdx713 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000425503100034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2 | en_US |
pubs.notes | 12 months | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 29 | en_US |